Labshake search
Citations for R&D Systems :
301 - 350 of 940 citations for 5 Isoxazolol 4 methyl 3 trifluoromethyl 9CI since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Synthetic Biology 2020Quote: ... 10 ng/mL transforming growth factor beta 3 (TGF-β3, R&D Systems) and 100nM dexamethasone12,27 to make implantable cartilage constructs11 ...
-
bioRxiv - Cancer Biology 2022Quote: ... 3-day old organoids were harvested with Cultrex Harvesting Solution (R&D Systems) and frozen in Recovery Cell Culture Freezing Medium (GIBCO) ...
-
bioRxiv - Immunology 2023Quote: IFN-λ2/3 concentration was determined by commercial sandwich ELISA (R&D Systems) from supernatants infected or not with T ...
-
bioRxiv - Cancer Biology 2023Quote: ... 3-day old organoids were harvested with Cultrex Harvesting Solution (R&D Systems) and frozen in Recovery Cell Culture Freezing Medium (GIBCO) ...
-
bioRxiv - Cell Biology 2023Quote: ... anti-Galectin-3 (1:50; R&D systems, AF1197 & 1:100; Biolegend, 125401), anti-Hsp70 (1:300 ...
-
bioRxiv - Neuroscience 2023Quote: ... goat anti-Human DKK-3 (1:1,000, R&D Systems, Cat# AF1118, RRID:AB_354610), rabbit anti-GAPDH (1:5,000 ...
-
bioRxiv - Neuroscience 2023Quote: ... goat anti-Mouse DKK-3 (1:1,000, R&D Systems, Cat# AF948, RRID:AB_355734), goat anti-Human DKK-3 (1:1,000 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Recombinant human galectin 3 binding protein (R&D Systems, and produced in-house), QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies) ...
-
bioRxiv - Immunology 2024Quote: ... containing 1 ng/mL IL-3 (R&D Systems in Minneapolis, MN, USA) at 37°C with 5% CO2.
-
bioRxiv - Microbiology 2022Quote: ... IL-4 (R&D Systems Cat#204-IL-050, 20ng/mL), αIgG (Agilent Cat#A042402-2) ...
-
bioRxiv - Immunology 2021Quote: ... 10 ng/mL IL-4 from R&D Systems (404-ML), and 3 μg/mL anti-IFN-γ was added ...
-
bioRxiv - Immunology 2020Quote: ... IL-4 and IL-13 were purchased from R&D Systems. Acid Phosphatase ...
-
bioRxiv - Cancer Biology 2021Quote: Recombinant 52-kDa pro-cath-D (4 µM; R&D Systems) was auto-activated to 51-kDa pseudo-cath-D in 0.1 M Na-acetate buffer (pH 3.5) ...
-
bioRxiv - Biochemistry 2022Quote: ... 20 ng/mL bone morphogenetic protein 4 (BMP4, R&D Systems), and 10 ng/mL fibroblast growth factor-basic (bFGF ...
-
bioRxiv - Developmental Biology 2019Quote: ... 4 ng human recombinant IGF2 (292-G2-050, R&D Systems) was used as positive control ...
-
bioRxiv - Cell Biology 2021Quote: ... 30 ng/ml Bone morphogenic protein-4 (BMP4) (R&D systems), 1.5 μM CHIR99021 (Stemgent) ...
-
bioRxiv - Microbiology 2020Quote: ... and 4,000 U/ml of rh IL-4 (R&D Systems) and cultured for 5 days ...
-
bioRxiv - Neuroscience 2022Quote: ... or IL-4 (20 ng/mL, 24 h, R&D Systems). Following stimulation ...
-
bioRxiv - Developmental Biology 2022Quote: ... BMP-4 (40 ng/ml, R&D Systems #5020-BP-010) or CHIR99021 (3 μM ...
-
bioRxiv - Cancer Biology 2022Quote: ... The caspase 4 inhibitor (Z-YVAD-FMK, FMK005, R&D systems) was used in further experiments at the dose of 50 µM ...
-
bioRxiv - Neuroscience 2023Quote: ... 4 µl of anti-V5-AF647 antibody (R&D Systems, FAB8926R) was used for staining cells for 20 minutes on a shaker at 500 rpm (Thermo Microplate Shaker) ...
-
bioRxiv - Bioengineering 2023Quote: ... and 20 ng/mL human recombinant FGF-4 (R&D Systems). After 9 to 13 days ...
-
bioRxiv - Microbiology 2024Quote: ... and IL-4 (R&D Systems, Cat# 6507-IL-025/CF) in complete RPMI ...
-
bioRxiv - Immunology 2024Quote: ... TNFα and IL-4 using ELISA kits from R&D Systems in accordance with the manufacturer’s instructions ...
-
bioRxiv - Immunology 2023Quote: ... and 50 μg/ml L-Ascorbic Acid)) supplemented with Growth Factor Cocktail (5 ng/ml BMP4, 5 ng/ml bFGF, 10 ng/ml IL-6 (R&D systems, 206-IL), 10 ng/ml Flt3L (PeproTech ...
-
bioRxiv - Developmental Biology 2021Quote: ... sheep anti-PAX6 (AF8150: R&D Systems, 5 µg/mL); rat anti-TBR2 (clone ...
-
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytesbioRxiv - Molecular Biology 2021Quote: ... 5 μg/mL soluble CD40L (R&D Systems, Minneapolis, MN), 10 μg/mL anti-His tag antibody (clone AD1.1.10 ...
-
bioRxiv - Microbiology 2021Quote: ... LL-37 (5 – 40 μg ml−1, R&D Systems), hNP-1 (0.625 – 10 μg ml−1 ...
-
bioRxiv - Bioengineering 2020Quote: ... 5 ng/ml hbFGF (233-FB; R&D systems, USA), and 1X Pen/Strep.
-
bioRxiv - Biophysics 2021Quote: ... and 5 ng/mL bFGF (R&D Systems, 223-FB). To avoid interference from lamellipodial protrusion/retraction cycles on T-Plastin recovery measurements ...
-
bioRxiv - Cell Biology 2021Quote: ... 5 μM of RepSox (R) (R&D Systems, 3742/50) and 3 μM of CHIR99021 (C ...
-
bioRxiv - Developmental Biology 2022Quote: ... 5 ng/ml basic fibroblast growth factor (R&D Systems), and 250 nM SANT1 (Cayman) ...
-
bioRxiv - Genomics 2021Quote: ... and E-cadherin (5 µg/ml, R&D Systems, #AF648) overnight ...
-
bioRxiv - Developmental Biology 2021Quote: ... 5 ng/ml mouse VEGF (R&D systems Cat. 494MV). For mesoderm induction in the AB regimen ...
-
bioRxiv - Immunology 2020Quote: ... and Mouse IL-5 Quantikine ELISA Kit (R&D System). The OD450 values were read by Multiskan GO (ThermoFisher).
-
bioRxiv - Developmental Biology 2023Quote: ... 5 ng/ml SHH (R&D Systems, cat# 8908-SH), 2 ng/ml JAG1 (1277-JG-050 ...
-
bioRxiv - Cancer Biology 2023Quote: ... TNFα (5 ng/m; R&D systems #210-TA-020) and IFNγ (25 IU/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... 5 μM Q-VD-OPh (R&D Systems, Abindgon, UK).
-
bioRxiv - Immunology 2019Quote: ... with rat anti-mouse IL-18 (1 μg/ml; D047-3; R&D Systems), rabbit anti-human IL-18 (0.2 μg/ml ...
-
bioRxiv - Bioengineering 2021Quote: ... and Human chitinase 3-like 1 (YKL-40) were purchased from R&D Systems. Bovine serum albumin was purchased from Sigma Aldrich ...
-
bioRxiv - Microbiology 2021Quote: ... and Human IL29/IL28B (IFN-lambda 1/3) DuoSet ELISA (DY1598B, R&D Systems). Protein levels of IFNλ from intestinal biopsies were measured by Mouse IL28B/ IFN-lambda 3 DuoSet ELISA (DY1789B ...
-
bioRxiv - Cancer Biology 2022Quote: ... cocultures were treated with 3 μg/ml IL1α-neutralizing antibody (#MAB4001, R&D Systems) or isotype control antibody (#400902 ...
-
bioRxiv - Molecular Biology 2022Quote: ... Recombinant human WNT3A and R-spondin 3 were from R&D Systems (Minneapolis, USA).
-
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residencybioRxiv - Immunology 2022Quote: ... FMS-like tyrosine kinase-3 ligand (FLT3-L) (100 ng/mL, R&D systems) and thrombopoietin (TPO ...
-
bioRxiv - Microbiology 2023Quote: Calu-3 cells were treated with exogenous β-IFN (R&D Systems, Minneapolis MN), baricitinib (Selleck Chemicals ...
-
bioRxiv - Microbiology 2023Quote: ... or 3 ug/ml of an anti-Dectin-1 antibody (MAB1859; R&D Systems). Mouse IgG was used as a control ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Neuroscience 2023Quote: cleaved caspase 3 (Cat. No. MAB835, 1:200 in blocking solution, R&D Systems), dsDNA (Cat No ...
-
bioRxiv - Immunology 2024Quote: ... 2mM L-Glutamine and 20ng/mL of recombinant human IL-3 (R&D systems). Cas9 and gRNA components were assembled into RNP per the manufacturer’s instructions and transfected into pDC 16 hrs p.c ...
-
bioRxiv - Neuroscience 2021Quote: 10 ng/mL BMP-4 (R&D Systems cat. no. 314-BP)